Øyvind Holme1, Michael Bretthauer2, Tor J Eide3, Else Marit Løberg3, Krzysztof Grzyb4, Magnus Løberg5, Mette Kalager6, Hans-Olov Adami7, Øystein Kjellevold8, Geir Hoff9. 1. Department of Medicine, Sørlandet Hospital, Kristiansand, Norway Institute of Health and Society, University of Oslo, Oslo, Norway. 2. Department of Medicine, Sørlandet Hospital, Kristiansand, Norway Institute of Health and Society, University of Oslo, Oslo, Norway Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. 3. Department of Pathology, Oslo University Hospital, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 4. Department of Pathology, Oslo University Hospital, Oslo, Norway. 5. Institute of Health and Society, University of Oslo, Oslo, Norway Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway. 6. Institute of Health and Society, University of Oslo, Oslo, Norway Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA Telemark Hospital, Skien, Norway. 7. Institute of Health and Society, University of Oslo, Oslo, Norway Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 8. Department of Medicine, Telemark Hospital, Kragerø, Norway. 9. Institute of Health and Society, University of Oslo, Oslo, Norway Telemark Hospital, Skien, Norway Cancer Registry of Norway, Oslo, Norway.
Abstract
OBJECTIVE: Although serrated polyps may be precursors of colorectal cancer (CRC), prospective data on the long-term CRC risk in individuals with serrated polyps are lacking. DESIGN: In a population-based randomised trial, 12,955 individuals aged 50-64 years were screened with flexible sigmoidoscopy, while 78 220 individuals comprised the control arm. We used Cox models to estimate HRs with 95% CIs for CRC among individuals with ≥1 large serrated polyp (≥10 mm in diameter), compared with individuals with adenomas at screening, and to population controls, and multivariate logistic regression to assess polyp risk factors for CRC. RESULTS: A total of 103 individuals had large serrated polyps, of which 81 were included in the analyses. Non-advanced adenomas were found in 1488 individuals, advanced adenomas in 701. Median follow-up was 10.9 years. Compared with the control arm, the HR for CRC was 2.5 (95% CI 0.8 to 7.8) in individuals with large serrated polyps, 2.0 (95% CI 1.3 to 2.9) in individuals with advanced adenomas and 0.6 (95% CI 0.4 to 1.1) in individuals with non-advanced adenomas. A large serrated polyp was an independent risk factor for CRC, adjusted for histology, size and multiplicity of concomitant adenomas (OR 3.3; 95% CI 1.3 to 8.6). Twenty-three large serrated polyps found at screening were left in situ for a median of 11.0 years. None developed into a malignant tumour. CONCLUSIONS:Individuals with large serrated polyps have an increased risk of CRC, comparable with individuals with advanced adenomas. However, this risk may not be related to malignant growth of the serrated polyp. TRIAL REGISTRATION NUMBER: The Norwegian Colorectal Cancer Screening trial is registered at clinicaltrials.gov (NCT00119912). Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
RCT Entities:
OBJECTIVE: Although serrated polyps may be precursors of colorectal cancer (CRC), prospective data on the long-term CRC risk in individuals with serrated polyps are lacking. DESIGN: In a population-based randomised trial, 12,955 individuals aged 50-64 years were screened with flexible sigmoidoscopy, while 78 220 individuals comprised the control arm. We used Cox models to estimate HRs with 95% CIs for CRC among individuals with ≥1 large serrated polyp (≥10 mm in diameter), compared with individuals with adenomas at screening, and to population controls, and multivariate logistic regression to assess polyp risk factors for CRC. RESULTS: A total of 103 individuals had large serrated polyps, of which 81 were included in the analyses. Non-advanced adenomas were found in 1488 individuals, advanced adenomas in 701. Median follow-up was 10.9 years. Compared with the control arm, the HR for CRC was 2.5 (95% CI 0.8 to 7.8) in individuals with large serrated polyps, 2.0 (95% CI 1.3 to 2.9) in individuals with advanced adenomas and 0.6 (95% CI 0.4 to 1.1) in individuals with non-advanced adenomas. A large serrated polyp was an independent risk factor for CRC, adjusted for histology, size and multiplicity of concomitant adenomas (OR 3.3; 95% CI 1.3 to 8.6). Twenty-three large serrated polyps found at screening were left in situ for a median of 11.0 years. None developed into a malignant tumour. CONCLUSIONS: Individuals with large serrated polyps have an increased risk of CRC, comparable with individuals with advanced adenomas. However, this risk may not be related to malignant growth of the serrated polyp. TRIAL REGISTRATION NUMBER: The Norwegian Colorectal Cancer Screening trial is registered at clinicaltrials.gov (NCT00119912). Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Xinwei Hua; Polly A Newcomb; Jessica Chubak; Rachel C Malen; Rebecca Ziebell; Aruna Kamineni; Lee-Ching Zhu; Melissa P Upton; Michelle A Wurscher; Sushma S Thomas; Hana Newman; Sheetal Hardikar; Andrea N Burnett-Hartman Journal: Cancer Causes Control Date: 2020-05-01 Impact factor: 2.506
Authors: Xiaosheng He; Kana Wu; Shuji Ogino; Edward L Giovannucci; Andrew T Chan; Mingyang Song Journal: Gastroenterology Date: 2018-04-24 Impact factor: 22.682
Authors: A Chino; N Yamamoto; Y Kato; K Morishige; H Ishikawa; T Kishihara; J Fujisaki; Y Ishikawa; Y Tamegai; M Igarashi Journal: Int J Colorectal Dis Date: 2015-10-29 Impact factor: 2.571
Authors: Chun-Han Lo; Long H Nguyen; Kana Wu; Shuji Ogino; Andrew T Chan; Edward L Giovannucci; Mingyang Song Journal: Cancer Prev Res (Phila) Date: 2020-08
Authors: Michael N Passarelli; Elizabeth L Barry; Judy R Rees; Leila A Mott; Dongyu Zhang; Dennis J Ahnen; Robert S Bresalier; Robert W Haile; Gail McKeown-Eyssen; Dale C Snover; Bernard F Cole; John A Baron Journal: Am J Clin Nutr Date: 2019-10-01 Impact factor: 7.045
Authors: Lisandro Pereyra; Rafael Zamora; Estanislao Jesús Gómez; Carolina Fischer; Guillermo Nicolas Panigadi; Raquel González; Maximiliano Bun; José Manuel Mella; Mariana Omodeo; Pablo Luna; Marcelo Amante; Gabriel Casas; Silvia Pedreira; Daniel Cimmino; Luis Boerr Journal: Am J Gastroenterol Date: 2016-04-12 Impact factor: 10.864